Pharmacovigilance Market Size, Share, Trends, Growth Outlook

The Global Pharmacovigilance Market Size is estimated to register XX% growth over the forecast period from 2023 to 2030.

 

The market growth is driven by an increasing demand for high-quality, standardized data in pharmacovigilance is rising, driven by the need for accurate and consistent information for safety monitoring and regulatory compliance. Leading Companies focusing on the Application of Artificial Intelligence (AI) in Predictive Pharmacovigilance, Enhanced Patient Engagement and Decentralized Clinical Trials, Blockchain for Secure and Transparent Data Management, and others to boost market shares in the industry.

 

Market Overview

The pharmacovigilance market, centered on monitoring and ensuring drug safety, has witnessed substantial growth driven by increased regulatory scrutiny, outsourcing trends, and technological advancements such as artificial intelligence and big data analytics. Globalization of clinical trials, a patient-centric approach, and the emergence of next-generation pharmacovigilance systems have further characterized the industry. Challenges include the need for standardized data and addressing complexities in adverse event reporting. The future outlook anticipates a continued focus on technology integration, patient engagement, and proactive risk management, with the potential impact of blockchain and AI reshaping the pharmacovigilance landscape.

 

Market Dynamics

Market Trends- Pharmaceutical companies face an ever-growing labyrinth of regulatory requirements, necessitating a strategic approach to pharmacovigilance compliance.

Pharmaceutical companies confront escalating regulatory requirements, necessitating a strategic approach to pharmacovigilance compliance. The ever-evolving global regulatory landscape demands proactive measures, including robust adverse event reporting systems and the adoption of advanced technologies such as artificial intelligence and big data analytics. Successfully navigating these regulations requires continuous monitoring, a proactive stance, and the establishment of a compliance-focused culture within organizations. Prioritizing pharmacovigilance throughout drug development ensures not only compliance but also contributes to building a safer and more reliable pharmaceutical industry.

 

Market Driver- The escalating prevalence of Adverse Drug Reactions (ADRs) is propelling the demand for pharmacovigilance services, underscoring the need for robust drug safety monitoring and risk mitigation strategies.

The surge in Adverse Drug Reactions (ADRs) is driving an increased demand for pharmacovigilance services, underscoring the vital need for robust drug safety monitoring and risk mitigation in the pharmaceutical sector. The rising incidence highlights the industry's recognition of pharmacovigilance's crucial role in ensuring patient safety and regulatory compliance. Emphasizing the integration of advanced technologies, such as artificial intelligence and real-world evidence, is crucial for efficient ADR detection and risk management. In navigating this landscape, proactive pharmacovigilance measures are essential not only for regulatory adherence but also for maintaining public trust and confidence in the safety of pharmaceutical products.

 

Market Opportunity- The integration of advanced technologies into pharmacovigilance practices is transforming drug safety monitoring, enabling more efficient data collection, analysis, and risk assessment.

The incorporation of advanced technologies in pharmacovigilance is transforming drug safety monitoring, streamlining data collection, analysis, and risk assessment. This technological evolution, involving artificial intelligence, machine learning, and big data analytics, improves the speed and precision of identifying potential safety issues linked to pharmaceutical products. Automated signal detection and the analysis of extensive datasets enable early recognition of adverse events, fostering proactive risk management. Embracing these innovative technologies not only boosts the efficiency of pharmacovigilance but also ensures a swift response to emerging safety concerns, thereby enhancing patient safety and regulatory compliance in the pharmaceutical industry.

 

Market Share Analysis- Spontaneous Reporting Pharmacovigilance Market will register the fastest growth

The Global Pharmacovigilance Market is analyzed across Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining, and others. Spontaneous Reporting is poised to register the fastest growth. The Spontaneous Reporting Pharmacovigilance Market focuses on tools and services dedicated to managing voluntary reports of adverse drug reactions from healthcare professionals, patients, and consumers. This market plays a vital role in systematically collecting and analyzing data to enhance drug safety surveillance. It includes databases, signal detection algorithms, and reporting tools to organize information and facilitate communication between stakeholders. By proactively identifying safety issues, the Spontaneous Reporting Pharmacovigilance Market contributes to improved patient outcomes and regulatory compliance in the pharmaceutical industry.

 

Market Share Analysis- Phase IV held a significant market share in 2023

The Global Pharmacovigilance Market is analyzed across various Product Life Cycles including Pre-clinical, Phase I, Phase II, Phase III, Phase IV, and others. Of these, Phase IV held a significant market share in 2023. The Phase IV Pharmacovigilance Market is centered on post-marketing surveillance activities, focusing on real-world safety and efficacy monitoring of approved pharmaceutical products. It involves continuous data collection, analysis, and reporting to regulatory authorities, utilizing advanced technologies for signal detection and real-world evidence generation. This market segment is crucial for updating and maintaining drug safety profiles throughout a product's lifecycle, addressing safety concerns, and informing regulatory decisions and healthcare practices.

 

Pharmacovigilance Market Segmentation

By Type

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

By Product Life Cycle

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

By Service Provider

• In House
• Contract Outsourcing

By Process Flow

• Case Data Management
• Signal Detection
• Risk Management System

By Therapeutic Area

• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Others

By End-User

• Pharmaceuticals
• Biotechnology Companies
• Medical Device Manufacturers
• Others

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Pharmacovigilance Market Companies

• IQVIA
• IBM Corp
• Accenture
• Cognizant
• Clinquest Group B.V.
• Laboratory Corporation of America Holdings
• ArisGlobal
• Capgemini
• ITClinical
• United BioSource LLC
• ICON plc
• Parexel International Corp
• Wipro Ltd
• ClinChoice
• TAKE Solutions Ltd
• BioClinica Inc

 

*List not exhaustive

Pharmacovigilance Market Outlook 2023

1 Market Overview

1.1 Introduction to the Pharmacovigilance Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Pharmacovigilance Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Pharmacovigilance Market Companies with Area Served

4.2.2 Products Offerings Global Pharmacovigilance Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 post-COVID-19 Scenario- Reference Growth Case

5.1.4 post-COVID-19 Scenario- Low Growth Case

 

6 Global Pharmacovigilance Market Trends

6.1 Global Pharmacovigilance Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Pharmacovigilance Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Pharmacovigilance Revenue (USD Million) and CAGR (%) by regions (2018-2030)

 

7 Global Pharmacovigilance Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Pharmacovigilance Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Pharmacovigilance Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Pharmacovigilance Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Pharmacovigilance Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Pharmacovigilance Development Regional Status and Outlook

8.1 Global Pharmacovigilance Revenue (USD Million) By Regions (2018-2022)

8.2 North America Pharmacovigilance Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Pharmacovigilance Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Pharmacovigilance Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Pharmacovigilance Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Pharmacovigilance Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Pharmacovigilance Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Pharmacovigilance Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Pharmacovigilance Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Pharmacovigilance Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Pharmacovigilance Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Pharmacovigilance Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Pharmacovigilance Revenue (USD Million) by Applications (2018-2022)

8.5 South America Pharmacovigilance Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Pharmacovigilance Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Pharmacovigilance Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Pharmacovigilance Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Pharmacovigilance Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Pharmacovigilance Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Pharmacovigilance Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Pharmacovigilance Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Pharmacovigilance Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Pharmacovigilance Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Pharmacovigilance Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Pharmacovigilance Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Pharmacovigilance Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Pharmacovigilance Development Regional Status and Outlook Forecast

11.1 Global Pharmacovigilance Revenue (USD Million) By Regions (2023-2030)

11.2 North America Pharmacovigilance Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Pharmacovigilance Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Pharmacovigilance Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Pharmacovigilance Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Pharmacovigilance Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Pharmacovigilance Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Pharmacovigilance Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Pharmacovigilance Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Pharmacovigilance Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Pharmacovigilance Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Pharmacovigilance Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Pharmacovigilance Revenue (USD Million), by Applications (2023-2030)

11.5 South America Pharmacovigilance Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Pharmacovigilance Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Pharmacovigilance Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Pharmacovigilance Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Pharmacovigilance Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Pharmacovigilance Revenue (USD Million), by region (2023-2030)

11.6.2 Middle East and Africa Pharmacovigilance Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Pharmacovigilance Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Pharmacovigilance Market Companies with Areas Served

Table 3 Products Offerings Global Pharmacovigilance Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Pharmacovigilance Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Pharmacovigilance Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Pharmacovigilance Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Table 11 Global Pharmacovigilance Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Pharmacovigilance Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Pharmacovigilance Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Pharmacovigilance Market Share (%) By Regions (2018-2022)

Table 16 North America Pharmacovigilance Revenue (USD Million) By Country (2018-2022)

Table 17 North America Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Table 18 North America Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Pharmacovigilance Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Pharmacovigilance Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Pharmacovigilance Revenue (USD Million) By Country (2018-2022)

Table 26 South America Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Table 27 South America Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Table 33 Global Pharmacovigilance Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Pharmacovigilance Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Pharmacovigilance Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Pharmacovigilance Revenue (USD)By Country (2023-2030)

Table 38 North America Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Table 39 North America Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Pharmacovigilance Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Pharmacovigilance Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Pharmacovigilance Revenue (USD Million) By Country (2023-2030)

Table 47 South America Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Table 48 South America Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Pharmacovigilance Revenue Market Share (%) By Type (2022)

Figure 5 Global Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Pharmacovigilance Revenue Market Share (%) By Applications (2022)

Figure 7 Global Pharmacovigilance Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Pharmacovigilance Market Share (%) By Regions (2022)

Figure 9 North America Pharmacovigilance Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Pharmacovigilance Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Pharmacovigilance Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Pharmacovigilance Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Pharmacovigilance Revenue Market Share (%) By Type (2030)

Figure 26 Global Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Pharmacovigilance Revenue Market Share (%) By Applications (2030)

Figure 28 Global Pharmacovigilance Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Pharmacovigilance Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Pharmacovigilance Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Pharmacovigilance Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Pharmacovigilance Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Pharmacovigilance Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

 

Pharmacovigilance Market Segmentation

By Type

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

By Product Life Cycle

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

By Service Provider

• In House
• Contract Outsourcing

By Process Flow

• Case Data Management
• Signal Detection
• Risk Management System

By Therapeutic Area

• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Others

By End-User

• Pharmaceuticals
• Biotechnology Companies
• Medical Device Manufacturers
• Others

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)